AMRX PDUFA decision: a positive outcome, +9.8%

On July 5, 2018, Amneal Pharmaceuticals, Inc. reached its PDUFA decision. The result was a positive outcome, and the stock moved +9.8% in the window around the event. It had already run -10.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.